Compare Kato (Hong Kong) Holdings Ltd. with Similar Stocks
Dashboard
1
High Debt company with Weak Long Term Fundamental Strength
- The company is Net-Debt Free
2
With ROE of 10.82%, it has a Very Expensive valuation with a 1.05 Price to Book Value
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
4.35%
0%
4.35%
6 Months
0%
0%
0.0%
1 Year
-9.43%
0%
-9.43%
2 Years
-20.0%
0%
-20.0%
3 Years
-22.58%
0%
-22.58%
4 Years
-27.27%
0%
-27.27%
5 Years
-3.03%
0%
-3.03%
Kato (Hong Kong) Holdings Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.72%
EBIT Growth (5y)
-1.58%
EBIT to Interest (avg)
9.40
Debt to EBITDA (avg)
1.01
Net Debt to Equity (avg)
0.40
Sales to Capital Employed (avg)
0.62
Tax Ratio
27.30%
Dividend Payout Ratio
87.72%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
20.00%
ROE (avg)
23.47%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
1.05
EV to EBIT
8.80
EV to EBITDA
5.20
EV to Capital Employed
1.03
EV to Sales
1.84
PEG Ratio
NA
Dividend Yield
430.11%
ROCE (Latest)
11.75%
ROE (Latest)
10.82%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
353.80
317.10
11.57%
Operating Profit (PBDIT) excl Other Income
125.40
115.10
8.95%
Interest
10.40
15.60
-33.33%
Exceptional Items
-15.60
-25.00
37.60%
Consolidate Net Profit
33.70
21.10
59.72%
Operating Profit Margin (Excl OI)
193.90%
207.60%
-1.37%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 11.57% vs 16.88% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is 59.72% vs -67.08% in Mar 2025
About Kato (Hong Kong) Holdings Ltd. 
Kato (Hong Kong) Holdings Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






